Transforming Pathology: Insights from Clinical Trials on an FDA-Cleared Digital Pathology Scanner
Time: 2:20 pm
day: Day Two Track C
Details:
- Understand the clinical trial methodology and design used to evaluate the efficacy and safety of Leica’s FDA-cleared digital pathology scanner
- Explore the key findings and outcomes form the clinical trials, including accuracy and precision studies
- Discuss the potential impact of the FDA-cleared digital pathology scanner on biomarker development, diagnostic accuracy, workflow efficiency and patient care in clinical settings
